Spheno-orbital Lesions—A Major Review of Nonmeningioma Causes

AA McNab, RS Jones, TG Hardy - Ophthalmic Plastic & …, 2021 - journals.lww.com
Purpose: To review the imaging features of the broad range of nonmeningioma lesions of
the greater wing of the sphenoid (GWS) bone and adjacent orbit to assist clinicians in …

Orbital involvement in multiple myeloma

MK Shoji, Y Chen, NJ Topilow… - Ophthalmic Plastic & …, 2023 - journals.lww.com
Purpose: To characterize clinical and radiographic features, management, and outcomes of
patients with orbital involvement of multiple myeloma (MM). Methods: A retrospective chart …

Successful treatment of refractory orbital plasmacytoma with chimeric antigen receptor t cell therapy: a case report and review of the literature

RZ Lin, T Lu, N Homer, CJ Men - Ophthalmic Plastic & …, 2024 - journals.lww.com
Orbital plasmacytoma is a rare plasma cell tumor that may arise as an aggressive form of
extramedullary multiple myeloma. Treatment modalities include surgical excision, radiation …

Orbital plasmacytoma as the presenting feature in multiple myeloma

M Mani, N Kasturi, R Sravya… - European Journal …, 2021 - journals.sagepub.com
A 50-year-old female patient presented with protrusion of the left eye for 1 month.
Examination showed abaxial proptosis, restriction of extraocular movements, and elevated …

A case series of aggressive orbital plasmacytomas

N Permaisuari, N Anggraini, M Mahyuddin… - Ocular Oncology and …, 2022 - karger.com
Purpose: Orbital plasmacytoma is a tumor of plasma cells located in the orbit, which is
uncommon and only accounts for less than 1% of total orbital tumors. Sixty-five percent of …

[HTML][HTML] Clinical features and prognosis of multiple myeloma and orbital extramedullary disease: seven cases report and review of literature

WL Hu, JY Song, X Li, XJ Pei, JJ Zhang… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Multiple myeloma (MM) complicated with extramedullary disease (EMD)
has a poor prognosis and is a limiting factor in the treatment of MM, and no standard …

Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report

S Sakano, H Matsuyama, H Ishikawa, A Shindo, Y Ii… - BMC neurology, 2020 - Springer
Background The onset of myasthenia (MG) gravis with anti-muscle-specific tyrosine kinase
(MuSK) antibodies most commonly peaks in the fourth decade of life, and MG with MuSK …

Orbital involvement in long-standing multiple myeloma

BB Panda, A Kar, B Moharana, P Mishra - BMJ Case Reports, 2023 - search.proquest.com
Previous literature review regarding orbital involvement in multiple myeloma reveals that it
can mimic orbital cellulitis, orbital abscess, dacryoadenitis, lacrimal gland tumour, eyelid …

A Case Series of Aggressive Orbital Plasmacytomas

NPNAM Mahyuddina, EKW Rajabtoc - 2022 - karger.com
Purpose: Orbital plasmacytoma is a tumor of plasma cells located in the orbit, which is
uncommon and only accounts for less than 1% of total orbital tumors. Sixty-five percent of …

Orbital Multiple Myeloma

J Aujla, V Juniat, S Patel, D Selva - Atlas of Orbital Imaging, 2020 - Springer
Key features of orbital multiple myeloma (MM): Median age at diagnosis: 70 years Equal
gender distribution Majority already diagnosed with MM Unilateral bony tumors (involving …